OGDH and cancer: However, neither a specific contribution of PDH and OGDH, nor a potential involvement of other lipoate-reactive systems [30, 31], including the thioredoxin system [32, 33], which is a known target of anti-cancer therapies [34], can be resolved using the lipoic acid analog.